Patents by Inventor Robin S. Quartin

Robin S. Quartin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified nucleotide compounds
    Patent number: 7495088
    Abstract: Disclosed is a nuclease resistant nucleotide compound capable of hybridizing with a complementary RNA in a manner which inhibits the function thereof, which modified nucleotide compound includes at least one component selected from the group consisting of MN3M, B(N)xM and M(N)xB wherein N is a phosphodiester-linked modified 2?-deoxynucleoside moiety; M is a moiety that confers endonuclease resistance on said component and that contains at least one modified or unmodified nucleic acid base; B is a moiety that confers exonuclease resistance to the terminus to which it is attached; and x is an integer of at least 2.
    Type: Grant
    Filed: June 28, 1994
    Date of Patent: February 24, 2009
    Assignee: Enzo Life Sciences, Inc.
    Inventors: Christine L. Brakel, James G. Wetmur, Robin S. Quartin
  • Nucleic acid displacer compositions and cells comprising same
    Patent number: 6358685
    Abstract: Procedures and compositions for forming and stabilizing non stable branch migrated oligo- and polydeoxynucleotides utilizing a displacer which is either single stranded or partially double stranded and hybridized to a linker strand. The displacer may contain one or more modified nucleotides.
    Type: Grant
    Filed: August 31, 1999
    Date of Patent: March 19, 2002
    Assignee: Enzo Therapeutics, Inc.
    Inventors: James G. Wetmur, Robin S. Quartin, Dean L. Engelhardt
  • Branch migration of nucleotides
    Patent number: 5958681
    Abstract: Procedures and compositions for forming and stabilizing non stable branch migrated oligo- and polydeoxynucleotides utilizing a displacer which is either single stranded or partially double stranded and hybridized to a linker strand. The displacer may contain one or more modified nucleotides.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 28, 1999
    Assignee: Enzo Therapeutics, Inc.
    Inventors: James G. Wetmur, Robin S. Quartin, Dean L. Engelhardt